Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-12-22 Purchase |
2022-01-03 06:13 am |
Petros Pharmaceuticals Inc. | PTPI | SHULMAN JOHN D JCP III SM AIV L.P. METP Holdings LLC Juggernaut Partners III GP L.P. Juggernaut Partners III GP Ltd. Director 10% Owner |
145,773 | $3.43 | $500,001 | 5,812,873 (Indirect) |
View |
| 2021-11-29 Purchase |
2021-11-30 2:49 pm |
Petros Pharmaceuticals Inc. | PTPI | SHULMAN JOHN D JCP III SM AIV L.P. METP Holdings LLC Juggernaut Partners III GP L.P. Juggernaut Partners III GP Ltd. Director 10% Owner |
500,000 | $3 | $1,500,000 | 5,932,771 (Indirect) |
View |
| 2021-10-18 Purchase |
2021-10-21 08:47 am |
Petros Pharmaceuticals Inc. | PTPI | SHULMAN JOHN D JCP III SM AIV L.P. METP Holdings LLC Juggernaut Partners III GP L.P. Juggernaut Partners III GP Ltd. Director 10% Owner |
1,661,807 | $1.715 | $2,849,999 | 6,719,578 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2020-12-01 Option Award(A) |
2020-12-28 7:46 pm |
N/A N/A |
Petros Pharmaceuticals Inc. | PTPI | SHULMAN JOHN D Juggernaut Partners III GP L.P. Juggernaut Partners III GP Ltd. METP Holdings LLC JCP III SM AIV L.P. Metuchen Therapeutics LLC Director 10% Owner |
3,395,964 | $0 | 3,395,964 (Indirect) |
View |
Ownership(A) |
2020-12-28 7:45 pm |
N/A N/A |
Petros Pharmaceuticals Inc. | PTPI | SHULMAN JOHN D Metuchen Therapeutics LLC METP Holdings LLC JCP III SM AIV L.P. Juggernaut Partners III GP L.P. Juggernaut Partners III GP Ltd. Director 10% Owner |
0 | $0 | 100 (Indirect) |
View |